|Day's Range||80.58 - 85.76|
|52 Week Range||31.38 - 86.92|
|PE Ratio (TTM)||-17.16|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
How Alnylam, Puma, Immunogen, Sangamo, and Calithera beat all others to be the best biotech stocks of the year so far.
Shares of Alnylam Pharmaceuticals, Inc. (ALNY) soared 93.3% this year so far massively outperforming the 2.6% increase registered by the Zacks classified Biomed/Genetics industry during this period.
Alnylam (ALNY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.